Cancellations and suspensions
This database records details of medicines and medical devices that have been cancelled or suspended, and no longer appear in the ARTG.
Following a review by the TGA, complementary medicines can be cancelled from the Australian Register of Therapeutic Goods. These cancellations are made by the Secretary under section 30 of the Therapeutic Goods Act 1989.
Where other actions are taken in relation to safety, a link to the TGA's safety alert will be included in the database under 'Further information'.
The reasons for a cancellation are stated in the database below under 'Grounds for cancellation'.
The heading 'Decision status' provides updated information about cancellation decisions, for example information about any decision to revoke a cancellation decision. It will not appear in every entry.
To find out whether a product is currently authorised for supply in Australia, check the ARTG.
Last updated
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Action
- Medical device cancellation (855)
- Medicine suspension (506)
- Complementary medicine cancellation (206)
- Medical device suspension (89)
- Medicine cancellation (59)
- Revocation of a TGA issued Conformity Assessment Certificate (55)
- Voluntary revocation at the request of the manufacturer (39)
- Medical device cancellation - certain devices within an entry (23)
- Registered medicine cancellation (14)
- Medical device cancellation - requested by the sponsor - certain devices within an entry (8)
- Medical device cancellation (7)
- Listed medicine cancellation (5)
- Complementary medicine cancellation (4)
- Listed medicine cancellation (4)
- Revocation of a TGA issued Conformity Assessment Certificate. (3)
- Revocation of medical device suspension (3)
- Revoked medicine suspension (2)
- AFT Pharmaceuticals Pty Ltd (1)
- Alphapharm Pty Ltd (1)
- Complementary Medicine Cancellation (1)
- Medical device cancellation (1)
- Suspension from the ARTG under subsection s41GA(1)(b) (1)
- Voluntary revocation at the request of the manufacturer. (1)
Find out more about Cancellations and Suspensions.
Search
1921 result(s) found, displaying 1 to 25
-
Cancellation or suspensionThe medicine is not eligible for listing (paragraph 30(1A)(a) of the Act).
It appears to the Secretary that the presentation of the goods is unacceptable (paragraph 30(2)(aa) of the Act).
The goods do not conform to a standard applicable to the goods (paragraph 30(2)(e) of the Act). -
Cancellation or suspensionThe sponsor failed to comply within 20 working days after a notice was given under section 31 requiring it to provide information or documents about the certifications made in relation to the goods.
-
Cancellation or suspensionFailure to comply with an automatic condition of inclusion under subsection 41FN(5A) of the Act.
-
Cancellation or suspensionFailure to comply with an automatic condition of inclusion under subsection 41FN(5A) of the Act.
-
Cancellation or suspensionThe sponsor failed to comply with a notice under section 41JA of the Act within a further 10 working days.
-
Cancellation or suspensionSponsor failed to comply with a notice under section 41JA of the Act within a further 10 working days
-
Cancellation or suspensionUnder subsection 41GA(1)(b) it is likely that there are grounds for cancelling the entry of the kind of device from the Register
-
Cancellation or suspensionThe Secretary is satisfied that the goods are not therapeutic goods (paragraph 9F(1)(b) of the Act)
-
Cancellation or suspensionThe Secretary is satisfied that the goods are not therapeutic goods (paragraph 9F(1)(b) of the Act)
-
Cancellation or suspensionCancelled from the ARTG under paragraphs 30(2)(a) and 30(2)(aa) of the Act
-
Cancellation or suspensionRegulatory action under subsection 41GA(1)(b) it is likely that there are grounds for cancelling the entry of the kind of device from the Register
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2026
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2026
-
Cancellation or suspensionRegulatory action due to voluntary revocation at the request of the manufacturer, effective 15 May 2025
-
Cancellation or suspensionRegulatory action due to voluntary revocation at the request of the manufacturer, effective 23 December 2025
-
Cancellation or suspensionRegulatory action due to voluntary revocation at the request of the manufacturer, effective 15 July 2025
-
Cancellation or suspensionRegulatory action due to voluntary revocation at the request of the manufacturer, effective 02 December 2025
-
Cancellation or suspensionRegulatory action due to voluntary revocation at the request of the manufacturer, effective 15 May 2025
-
Cancellation or suspensionRegulatory action due to voluntary revocation at the request of the manufacturer, effective 15 May 2025
-
Cancellation or suspensionRegulatory action due to voluntary revocation at the request of the manufacturer, effective 30 May 2025
-
Cancellation or suspensionRegulatory action due to voluntary revocation at the request of the manufacturer, effective 8 August 2025
-
Cancellation or suspensionRegulatory action due to voluntary revocation at the request of the manufacturer, effective 21 August 2025
-
Cancellation or suspensionRegulatory action due to voluntary revocation at the request of the manufacturer, effective 11 August 2025
-
Cancellation or suspensionRegulatory action due to voluntary revocation at the request of the manufacturer, effective 11 August 2025
-
Cancellation or suspensionRegulatory action due to voluntary revocation at the request of the manufacturer, effective 15 July 2025
Last updated